Bevacizumab in brain tumors: ready for primetime? - Suppr | 超能文献

Bevacizumab in brain tumors: ready for primetime?

作者信息

Franceschi Enrico, Tosoni Alicia, Girardi Fabio, Brandes Alba A

出版信息

Future Oncol. 2009 Oct;5(8):1183-4. doi: 10.2217/fon.09.98.

DOI:10.2217/fon.09.98

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Bevacizumab in brain tumors: ready for primetime?

Future Oncol. 2009 Oct;5(8):1183-4. doi: 10.2217/fon.09.98.

2

Bevacizumab--news from the fast lane?贝伐单抗——来自快车道的消息？

Neuro Oncol. 2008 Oct;10(5):647. doi: 10.1215/15228517-2008-074. Epub 2008 Sep 5.

3

Trastuzumab in CNS progressive metastatic breast cancer.

Future Oncol. 2007 Aug;3(4):367-9. doi: 10.2217/14796694.3.4.367.

4

Survival after brain metastases from breast cancer in the trastuzumab era.曲妥珠单抗时代乳腺癌脑转移后的生存情况。

J Clin Oncol. 2005 Mar 20;23(9):2114-6; author reply 2116-7. doi: 10.1200/JCO.2005.05.249.

5

Approval denied by the European Medicines Agency (EMA) for bevacizumab in the treatment of high-grade glioma recurrence: a good idea or a grave error?欧洲药品管理局（EMA）拒绝批准贝伐单抗用于治疗高级别胶质瘤复发：这是个好主意还是严重错误？

Clin Transl Oncol. 2011 Mar;13(3):209-10. doi: 10.1007/s12094-011-0642-9.

6

Clinical utility of continuing trastuzumab beyond brain progression in HER-2 positive metastatic breast cancer.HER-2阳性转移性乳腺癌脑转移进展后继续使用曲妥珠单抗的临床效用

Oncologist. 2007 Dec;12(12):1467-9; author reply 1469-71. doi: 10.1634/theoncologist.12-12-1467.

7

Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzumab-based therapy for metastatic breast cancer.对于先前接受基于曲妥珠单抗治疗转移性乳腺癌的脑转移患者使用曲妥珠单抗的理论依据。

Breast. 2005 Oct;14(5):425. doi: 10.1016/j.breast.2004.08.016.

8

Safety of bevacizumab with fluoropyrimidine-based regimens for first-line treatment of metastatic colorectal cancer.贝伐单抗联合氟嘧啶类方案用于转移性结直肠癌一线治疗的安全性

Clin Colorectal Cancer. 2006 Sep;6(3):189-91. doi: 10.1016/S1533-0028(11)70281-X.

9

In focus: bevacizumab for renal cell carcinoma.聚焦：贝伐单抗用于治疗肾细胞癌。

Clin Adv Hematol Oncol. 2005 Jan;3(1):68-9.

10

New agents in colon cancer.结肠癌的新型药物

Clin Adv Hematol Oncol. 2003 Jul;1(7):404-5.

引用本文的文献

1

Anti-metastatic effect of 131I-labeled Buthus martensii Karsch chlorotoxin in gliomas.131I 标记的蛛毒氯毒素对脑胶质瘤的抗转移作用。

Int J Mol Med. 2018 Dec;42(6):3386-3394. doi: 10.3892/ijmm.2018.3905. Epub 2018 Oct 1.

2

Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy.贝伐单抗、替莫唑胺与放疗用于新诊断的胶质母细胞瘤：一线治疗期间及之后的综合安全性结果

Neuro Oncol. 2016 Jul;18(7):991-1001. doi: 10.1093/neuonc/nov300. Epub 2016 Jan 24.

3

Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme.靶向Talin1通过减弱多形性胶质母细胞瘤的侵袭和干细胞样特征来增强抗血管生成治疗。

Oncotarget. 2015 Sep 29;6(29):27239-51. doi: 10.18632/oncotarget.4835.